Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet's Disease: A Post-Marketing Surveillance.

Adv Ther · 2024 · PMC11550226 · PMID 39412631

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, when compared with the 2-year PMS of IFX for patients with refractory uveoretinitis in BD, the current study showed a trend toward a higher incidence of herpes zoster (2.4% vs 0.91%), tuberculosis (0.8% vs 0.30%), and serious infections (9.4% vs 3.66%) [ 34 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.